A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Office of Technology Licensing Bookmark and Share

Office of Technology Licensing (OTL)

The Office of Technology Licensing (OTL) is an institution wide resource that works closely with City of Hope inventors to identify, protect, and create effective strategies to commercially advance their inventions and technologies.
 
Researchers have designed a mobile phone app that enables patients to improve their self management of diabetes via food and lifestyle choices.
 
Have you created a novel invention during the course of your research and would like to learn about how to build a start-up company around your discovery? Contact OTL and we can guide you through the necessary steps and help you start your company.
 
City of Hope's main focus is on translational research and developing new therapies. To that end we partner extensively with industry in hundreds of clinical trials and sponsored research projects each year. To support this aspiration, the CATD provides cGMP manufacturing of biologics at substantially reduced costs as compared with CMOs.

Below is a brief overview of the core services the Office of Technology Licensing offers to City of Hope investigators.
 
  • Meeting with City of Hope investigators to discuss new discoveries and inventions
 
  • Developing strategies to protect discoveries and inventions with patents, trademarks and copyrights while preserving academic values
 
  • Commercializing inventions and discoveries with industry partners to create novel therapeutics, diagnostics and research tools
 
  • Creating start-up companies around technologies developed at City of Hope
 
  • Negotiating and formalizing partnership agreements such as industry sponsored research, material transfer, confidentiality and inter-institutional agreements
 
  • Compliance with City of Hope policies and procedures related to materials, confidentiality and intellectual property, along with input from other teams at City of Hope
 
  • Organizing educational events focused on intellectual property, technology commercialization and entrepreneurship
 
 

About the Office of Technology Licensing

The OTL Team
The Office of Technology Licensing (OTL) is an institution-wide resource that works closely with City of Hope inventors to identify, protect and create effective strategies to realize the commercial potential of their inventions and technologies.
 
To achieve this goal, the OTL has several responsibilities. The OTL is responsible for developing intellectual property protection strategies that include the utilization of patents, trademarks and copyrights. The OTL also identifies and develops strategic partnerships with companies for potential licensing opportunities as well as collaborations to further develop these technologies. When a company makes the decision to license a technology, the OTL negotiates mutually beneficial license agreements to ensure that the commercial partner will commit and devote necessary resources to enable the successful development of these technologies and that the City of Hope will receive fair royalty rates and fees. The revenue generated from licenses is shared with our inventors and also with City of Hope to support future research.
 
We also help our entrepreneurial inventors to start their own companies around platform technologies. We have developed relationships with various investors including local angel investors and venture capitalists to encourage the formation of start-up companies.
 
In addition to the OTL’s mission to commercialize technologies, we devote a large portion of our time to catalyze research collaborations through the management and execution of material transfer agreements, confidential disclosure agreements and research collaboration agreements.

Office of Technology Licensing

The City of Hope Office of Technology Licensing team brings a wide array of experiences from both academia and industry in life sciences. The combination of each team member’s unique experience and background creates a well-rounded team. Our team is here to serve our investigators to assist in the advancement of their research and inventions. Feel free to contact members of the team with questions, comments or concerns about the OTL.

Office of Technology Licensing

Office of Technology Licensing (OTL)

The Office of Technology Licensing (OTL) is an institution wide resource that works closely with City of Hope inventors to identify, protect, and create effective strategies to commercially advance their inventions and technologies.
 
Researchers have designed a mobile phone app that enables patients to improve their self management of diabetes via food and lifestyle choices.
 
Have you created a novel invention during the course of your research and would like to learn about how to build a start-up company around your discovery? Contact OTL and we can guide you through the necessary steps and help you start your company.
 
City of Hope's main focus is on translational research and developing new therapies. To that end we partner extensively with industry in hundreds of clinical trials and sponsored research projects each year. To support this aspiration, the CATD provides cGMP manufacturing of biologics at substantially reduced costs as compared with CMOs.

Below is a brief overview of the core services the Office of Technology Licensing offers to City of Hope investigators.
 
  • Meeting with City of Hope investigators to discuss new discoveries and inventions
 
  • Developing strategies to protect discoveries and inventions with patents, trademarks and copyrights while preserving academic values
 
  • Commercializing inventions and discoveries with industry partners to create novel therapeutics, diagnostics and research tools
 
  • Creating start-up companies around technologies developed at City of Hope
 
  • Negotiating and formalizing partnership agreements such as industry sponsored research, material transfer, confidentiality and inter-institutional agreements
 
  • Compliance with City of Hope policies and procedures related to materials, confidentiality and intellectual property, along with input from other teams at City of Hope
 
  • Organizing educational events focused on intellectual property, technology commercialization and entrepreneurship
 
 

About OTL

About the Office of Technology Licensing

The OTL Team
The Office of Technology Licensing (OTL) is an institution-wide resource that works closely with City of Hope inventors to identify, protect and create effective strategies to realize the commercial potential of their inventions and technologies.
 
To achieve this goal, the OTL has several responsibilities. The OTL is responsible for developing intellectual property protection strategies that include the utilization of patents, trademarks and copyrights. The OTL also identifies and develops strategic partnerships with companies for potential licensing opportunities as well as collaborations to further develop these technologies. When a company makes the decision to license a technology, the OTL negotiates mutually beneficial license agreements to ensure that the commercial partner will commit and devote necessary resources to enable the successful development of these technologies and that the City of Hope will receive fair royalty rates and fees. The revenue generated from licenses is shared with our inventors and also with City of Hope to support future research.
 
We also help our entrepreneurial inventors to start their own companies around platform technologies. We have developed relationships with various investors including local angel investors and venture capitalists to encourage the formation of start-up companies.
 
In addition to the OTL’s mission to commercialize technologies, we devote a large portion of our time to catalyze research collaborations through the management and execution of material transfer agreements, confidential disclosure agreements and research collaboration agreements.

Meet the Team

Office of Technology Licensing

The City of Hope Office of Technology Licensing team brings a wide array of experiences from both academia and industry in life sciences. The combination of each team member’s unique experience and background creates a well-rounded team. Our team is here to serve our investigators to assist in the advancement of their research and inventions. Feel free to contact members of the team with questions, comments or concerns about the OTL.
Overview
Office of Technology Licensing
City of Hope
1500 E. Duarte Rd.
Modular 101
Duarte, CA 91010
 
 
 
Center for Applied Technology Development (CATD)
The Sylvia R. and Isador A. Deutch Center for Applied Technology Development (CATD) offers broad expertise in technology transfer and licensing, biologics manufacturing, quality assurance and regulatory affairs.

City of Hope Campus Map
 
 
 
 
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
NEWS & UPDATES
  • Beyond the pink ribbons, special product fundraisers, and the pastel sea of color that marks October, Breast Cancer Awareness Month offers a reason to celebrate and to reflect. More than 2.8 million breast cancer survivors live in the U.S. They are survivors of the second most-common cancer in women, behind ski...
  • Gliomas, a type of tumor that grows in the brain, are very difficult to treat successfully due to their complex nature. That might not always be the case. First some background: The most aggressive and common type of primary brain tumor in adults is glioblastoma. Although the brain tumor mass can often be remov...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. The result is rashes and, sometimes, tumors, which can be mistaken for other dermatological conditions. In a smal...
  • Weighing your breast cancer risk? One study suggests a measure to consider is skirt size. A British study suggests that for each increase in skirt size every 10 years after age 25, the five-year risk of developing breast cancer postmenopause increases from one in 61 to one in 51 – a 77 percent increase in risk....
  • Runners prize medals for 5Ks and marathons. Becky Stokes has a medal she cherishes from a very different kind of race: the marathon of treatments necessary to beat her aggressive triple-negative breast cancer. Just a week ago, she completed her last radiation treatment, and danced in the hospital with the staff...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free. Darakjian’s s...
  • The environment plays a role in causing cancer – this much we know. But scientists are still trying to understand what that role is, what environmental factors are in play and how precisely those factors are linked to cancer. Now City of Hope researchers have unlocked a clue as to how one carcinogen triggers ca...
  • Jonathan Yamzon, M.D., assistant clinical professor of surgery in the Division of Urology and Urologic Oncology, explains his approach to what’s known as “active surveillance” of men with prostate cancer. Patients need to be educated about their treatment options, he writes. Active surveillanc...
  • For most prostate cancer patients, surgery or radiation therapy is the initial and primary treatment against the disease. But some patients can benefit from chemotherapy and hormone therapy too, especially if there are signs of a relapse or if the cancer has spread beyond the prostate gland. Here, Cy Stein, M.D...
  • Cancer research has yielded scientific breakthroughs that offer patients more options, more hope for survival and a higher quality of life than ever before. The 14.5 million cancer patients living in the United States are living proof that cancer research saves lives. Now, in addition to the clinic, hospital an...
  • Advances in cancer treatment, built on discoveries made in the laboratory then brought to the bedside, have phenomenally changed the reality of living with a cancer diagnosis. More than any other time in history, people diagnosed with cancer are more likely to survive and to enjoy a high quality of life. Howeve...
  • While health care reform has led to an increase in the number of people signing up for health insurance, many people remain uninsured or are not taking full advantage of the health benefits they now have. Still others are finding that, although their premiums are affordable, they aren’t able to see the do...
  • Kidney cancer rates and thyroid cancer rates in adults have continued to rise year after year. Now a new study has found that incidence rates for these cancers are also increasing in children — particularly in African-American children. The study, published online this month in Pediatrics, examined childhood ca...
  • Thyroid cancer has become one of the fastest-growing cancers in the United States for both men and women. The chance of being diagnosed with the cancer has nearly doubled since 1990. This year an estimated 63,000 people will be diagnosed with thyroid cancer in the United States and nearly 1,900 people will die ...
  • Older teenagers and young adults traditionally face worse outcomes than younger children when diagnosed with brain cancer and other central nervous system tumors. A first-of-its-kind study shows why. A team of researchers from the departments of Population Sciences and Pathology at City of Hope recently examine...